TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
JBIO

Jade Biosciences, Inc.

Healthcare · Biotechnology

16.90$ -1.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement JBIO
Line item 2020 2021 2022 2023 2024 2025
+1,400.0% +353.3% +41.2% +193.8% -90.8%
+88.8% +157.7% +66.3% -17.2% +75.1%
+234,809.4%
+158.9% +131.1% +52.9% -8.6% +52.8%
+733.3% +124.0% -1.8% +5.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?